A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose- Response Trial of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures, with Optional Open-Label Extension

Grants and Contracts Details

StatusFinished
Effective start/end date3/28/143/31/16

Funding

  • PPD Development Inc: $9,225.00